References
- Bayraktar A, Erbaş D, Akarca Dizakar SÖ, Göktaş T, Ömeroğlu S, Öz Oyar E. The effect of hepcidin on cardiac ischemia-reperfusion injury. J Invest Surg. 2020;33(9):813–821. Octdoi:https://doi.org/10.1080/08941939.2019.1579275.
- Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med. 2007;357(11):1121–1135. doi:https://doi.org/10.1056/NEJMra071667.
- Teodoro JS, Varela AT, Duarte FV, Gomes AP, Palmeira CM, Rolo AP. Indirubin and NAD+ prevent mitochondrial ischaemia/reperfusion damage in fatty livers. Eur J Clin Invest. 2018;48(6):e12932. doi:https://doi.org/10.1111/eci.12932.
- Yu Y, Zhou CH, Yao YT, Li LH. Downregulation of Na+/Ca2+ exchanger isoform 1 protects isolated hearts by sevoflurane postconditioning but not by delayed remote ischemic preconditioning in rats. Chin Med J (Engl). 2017;130(18):2226–2233. doi:https://doi.org/10.4103/0366-6999.213967.
- De Hoog VC, Timmers L, Van Duijvenvoorde A, et al. Leucocyte expression of complement C5a receptors exacerbates infarct size after myocardial reperfusion injury. Cardiovasc Res. 2014;103(4):521–529. doi:https://doi.org/10.1093/cvr/cvu153.
- Vogel CW. The role of complement in myocardial infarction reperfusion injury: An underappreciated therapeutic target. Front Cell Dev Biol. 2020;8:606407. doi:https://doi.org/10.3389/fcell.2020.606407.
- Zhong C, Zhou Y, Liu H. Nuclear factor kappaB and anesthetic preconditioning during myocardial ischemia-reperfusion. Anesthesiology. 2004;100(3):540–546. Mardoi:https://doi.org/10.1097/00000542-200403000-00012.
- Chun N, Haddadin AS, Liu J, et al. Activation of complement factor B contributes to murine and human myocardial ischemia/reperfusion injury. PLoS One. 2017;12(6):e0179450. doi:https://doi.org/10.1371/journal.pone.0179450.
- Zhang XY, Liu Y, He T, et al. Anaphylatoxin C5a induces inflammation and reduces insulin sensitivity by activating TLR4/NF-kB/PI3K signaling pathway in 3T3-L1 adipocytes. Biomed Pharmacother. 2018;103:955–964. doi:https://doi.org/10.1016/j.biopha.2018.04.057.
- Zhang X, Kimura Y, Fang C, et al. Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo. Blood. 2007;110(1):228–236. doi:https://doi.org/10.1182/blood-2006-12-063636.
- Wang J, Yang L, Rezaie AR, Li J. Activated protein C protects against myocardial ischemic/reperfusion injury through AMP-activated protein kinase signaling. J Thromb Haemost. 2011;9(7):1308–1317. doi:https://doi.org/10.1111/j.1538-7836.2011.04331.x.
- Wang J, Wang Y, Wang J, et al. Antithrombin is protective against myocardial ischemia and reperfusion injury. J Thromb Haemost. 2013;11(6):1020–1028. doi:https://doi.org/10.1111/jth.12243.
- Ahrén B. Glucagon-like peptide-1 receptor agonists for type 2 diabetes: A rational drug development. J Diabetes Investig. 2019;10(2):196–201. Mardoi:https://doi.org/10.1111/jdi.12911.
- Ke J, Wei R, Yu F, Zhang J, Hong T. Liraglutide restores angiogenesis in palmitate-impaired human endothelial cells through PI3K/Akt-Foxo1-GTPCH1 pathway. Peptides. 2016;86:95–101. doi:https://doi.org/10.1016/j.peptides.2016.10.009.
- Liu C, Liu Y, He J, et al. Liraglutide increases VEGF expression via CNPY2-PERK pathway induced by hypoxia/reoxygenation injury. Front Pharmacol. 2019;10(789):789.
- Chen WR, Hu SY, Chen YD, et al. Effects of liraglutide on left ventricular function in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am Heart J. 2015;170(5):845–854. doi:https://doi.org/10.1016/j.ahj.2015.07.014.
- Chen WR, Chen YD, Tian F, et al. Effects of liraglutide on reperfusion injury in patients with ST-segment-elevation myocardial infarction. Circ Cardiovasc Imaging. 2016;9(12):e005146.
- Wu J, Xie F, Qin Y, Liu J, Yang Z. Notch signaling is involved in the antiapoptotic effects of liraglutide on rat H9c2 cardiomyocytes exposed to hypoxia followed by reoxygenation. J Int Med Res. 2020;48(9):300060520948394. doi:https://doi.org/10.1177/0300060520948394.
- Shiraki A, Oyama J, Komoda H, et al. The glucagon-like peptide 1 analog liraglutide reduces TNF-α-induced oxidative stress and inflammation in endothelial cells. Atherosclerosis. 2012;221(2):375–382. doi:https://doi.org/10.1016/j.atherosclerosis.2011.12.039.
- Liu YT, He T, Li HQ, Jiang P. Liraglutide improves pancreatic islet β cell apoptosis in rats with type 2 diabetes mellitus by inhibiting the IKKε/NF-κB pathway. Eur Rev Med Pharmacol Sci. 2021;25(14):4818–4828.
- Zhang XY, Huang Z, Li QJ, et al. Role of HSP90 in suppressing TLR4-mediated inflammation in ischemic postconditioning. Clin Hemorheol Microcirc. 2020;76(1):51–62. doi:https://doi.org/10.3233/CH-200840.
- Amour J, Brzezinska AK, Weihrauch D, et al. Role of heat shock protein 90 and endothelial nitric oxide synthase during early anesthetic and ischemic preconditioning. Anesthesiology. 2009;110(2):317–325. Febdoi:https://doi.org/10.1097/ALN.0b013e3181942cb4.
- Vladic N, Ge ZD, Leucker T, et al. Decreased tetrahydrobiopterin and disrupted association of Hsp90 with eNOS by hyperglycemia impair myocardial ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2011;301(5):H2130–9. Novdoi:https://doi.org/10.1152/ajpheart.01078.2010.
- Wang DX, Huang Z, Li QJ, et al. Involvement of HSP90 in ischemic postconditioning-induced cardioprotection by inhibition of the complement system, JNK and inflammation. Acta Cir Bras. 2020;35(1):e202000105.
- Zhong GQ, Tu RH, Zeng ZY, et al. Novel functional role of heat shock protein 90 in protein kinase C-mediated ischemic postconditioning. J Surg Res. 2014;189(2):198–206. doi:https://doi.org/10.1016/j.jss.2014.01.038.
- Hu SY, Zhang Y, Zhu PJ, Zhou H, Chen YD. Liraglutide directly protects cardiomyocytes against reperfusion injury possibly via modulation of intracellular calcium homeostasis. J Geriatr Cardiol. 2017;14(1):57–66.
- Dong Q, Sun L, Peng L, et al. PMX53 protects spinal cord from ischemia-reperfusion injury in rats in the short term. Spinal Cord. 2016;54(4):254–258. Aprdoi:https://doi.org/10.1038/sc.2015.146.
- Zhang K, Li GQ, He QH, Li Y, et al. C5a/C5aR pathway accelerates renal ischemia-reperfusion injury by downregulating PGRN expression. Int Immunopharmacol. 2017;53:17–23. doi:https://doi.org/10.1016/j.intimp.2017.10.006.
- Timmers L, Henriques JP, de Kleijn DP, et al. Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury. J Am Coll Cardiol. 2009;53(6):501–510. doi:https://doi.org/10.1016/j.jacc.2008.10.033.
- Nikolaidis LA, Mankad S, Sokos GG, et al. Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion. Circulation. 2004;109(8):962–965. doi:https://doi.org/10.1161/01.CIR.0000120505.91348.58.
- Hölscher C. Potential role of glucagon-like peptide-1 (GLP-1) in neuroprotection. CNS Drugs. 2012;26(10):871–882.
- Schopf FH, Biebl MM, Buchner J. The HSP90 chaperone machinery. Nat Rev Mol Cell Biol. 2017;18(6):345–360. doi:https://doi.org/10.1038/nrm.2017.20.
- Sreedhar AS, Nardai G, Csermely P. Enhancement of complement-induced cell lysis: a novel mechanism for the anticancer effects of Hsp90 inhibitors. Immunol Lett. 2004;92(1-2):157–161. doi:https://doi.org/10.1016/j.imlet.2003.11.025.
- Sreedhar AS, Mihály K, Pató B, et al. Hsp90 inhibition accelerates cell lysis. Anti-Hsp90 ribozyme reveals a complex mechanism of Hsp90 inhibitors involving both superoxide- and Hsp90-dependent events. J Biol Chem. 2003;278(37):35231–35240. doi:https://doi.org/10.1074/jbc.M301371200.
- Panagiotou A, Trendelenburg M, Osthoff M. The lectin pathway of complement in myocardial ischemia/reperfusion injury-review of its significance and the potential impact of therapeutic interference by C1 esterase inhibitor. Front Immunol. 2018;9:1151.doi:https://doi.org/10.3389/fimmu.2018.01151.
- Gorsuch WB, Chrysanthou E, Schwaeble WJ, Stahl GL. The complement system in ischemia-reperfusion injuries. Immunobiology. 2012;217(11):1026–1033. Novdoi:https://doi.org/10.1016/j.imbio.2012.07.024.
- Tang Y, Zhou G, Yao L, et al. Protective effect of Ginkgo biloba leaves extract, EGb761, on myocardium injury in ischemia reperfusion rats via regulation of TLR-4/NF-κB signaling pathway. Oncotarget. 2017;8(49):86671–86680. doi:https://doi.org/10.18632/oncotarget.21372.
- Guo R, Li G. Tanshinone modulates the expression of Bcl-2 and Bax in cardiomyocytes and has a protective effect in a rat model of myocardial ischemia-reperfusion. Hellenic J Cardiol. 2018;59(6):323–328. doi:https://doi.org/10.1016/j.hjc.2017.11.011.
- Yu B, Song B. Notch 1 signalling inhibits cardiomyocyte apoptosis in ischaemic postconditioning. Heart Lung Circ. 2014;23(2):152–158. Febdoi:https://doi.org/10.1016/j.hlc.2013.07.004.
- Sun G, Ye N, Dai D, Chen Y, Li C, Sun Y. The protective role of the TOPK/PBK pathway in myocardial ischemia/reperfusion and H2O2-induced injury in H9C2 cardiomyocytes. Int J Mol Sci. 2016;17(3):267. doi:https://doi.org/10.3390/ijms17030267.
- Zhang XY, Huang Z, Li QJ, et al. Ischemic postconditioning attenuates the inflammatory response in ischemia/reperfusion myocardium by upregulating miR-499 and inhibiting TLR2 activation. Mol Med Rep. 2020;22(1):209–218. Juldoi:https://doi.org/10.3892/mmr.2020.11104.